United States Pharmacopeial Convention
United States Pharmacopeial Convention reported $357.7 million in revenue and $333.6 million in expenses for the fiscal year ending June 30, 2025. Of every $100 it spent, $71.22 went to program services, $28.48 to management and general costs and $0.30 to fundraising. Its largest source of revenue was program service revenue such as fees, sales and contracts: 87.2% of the total. Government grants made up 6.1%. The highest compensation it reported for one person was $1,104,534 (CHIEF EXECUTIVE OFFICER & EX-OFFICIO). 683 people received more than $100,000 in reportable compensation. Revenue rose 12% between FY2020 and FY2025. Source: Form 990, FY2025.
Where $100 of spending went
The fiscal year ending June 30, 2025 · Form 990, Part IX, line 25 · total expenses $334MFor context, the median across 5,634 covered health care charities: $86.19 programs, $13.81 management, $0.00 fundraising (medians computed separately, so they may not sum to $100).
Where $100 of revenue came from
The fiscal year ending June 30, 2025 · Form 990, Part VIII · total revenue $358MThe 990 scorecard · same measures for every charity, no grades
| Measure | FY2025 | Median |
|---|---|---|
| Program services Part IX 25(B) ÷ 25(A) | 71.2% | 85.6% |
| Management & general Part IX 25(C) ÷ 25(A) | 28.5% | 13.7% |
| Fundraising Part IX 25(D) ÷ 25(A) | 0.3% | 0.0% |
| Fundraising cost per $1 of contributions Part IX 25(D) ÷ Part VIII 1h | $0.04 | $0.00 |
| Contributions & grants share of revenue Part VIII 1h ÷ 12 | 6.6% | 1.3% |
| Government grants share of revenue Part VIII 1e ÷ 12 | 6.1% | 0.1% |
| Program service revenue share Part VIII 2g ÷ 12 | 87.2% | 93.7% |
| Highest reported compensation Part VII-A, columns D–F | $1,104,534 | $975,831 |
| Highest compensation as share of expenses Part VII-A ÷ Part IX 25(A) | 0.33% | 1.34% |
| People paid over $100,000 Part VII, line 2 | 683 | 27 |
| Net assets, in months of expenses Part X 33(B) ÷ monthly expenses | 21.8 | 6.6 |
| Independent voting board members Part VI 1a–1b | 13 of 13 | 88.9% |
A median is context, not a target: hospitals, universities, food banks and grantmakers spend in very different ways. What these measures can and can't tell you.
What the money paid for, in its own words
FY2025 · Form 990, Part III · the three largest programs by expenseHighest reported compensation
FY2025 · Form 990, Part VII, Section A · roles as filed; names are in the filing, not here| Role | From this org | From related orgs | Other | Total |
|---|---|---|---|---|
| CHIEF EXECUTIVE OFFICER & EX-OFFICIO Officer, 38.00 hrs/week | $975,149 | $0 | $129,385 | $1,104,534 |
| EVP & CHIEF SCIENCE OFFICER Officer, 38.00 hrs/week | $618,546 | $0 | $89,510 | $708,056 |
| SECRETARY & SVP GLBL EA Officer, 38.00 hrs/week | $545,170 | $0 | $83,094 | $628,264 |
| VP, COMPENDIAL OPERATIONS Highest compensated employee, 38.00 hrs/week | $552,057 | $0 | $58,652 | $610,709 |
| SVP, LEGAL, STRATEGY & PEOPLE Officer, 38.00 hrs/week | $530,651 | $0 | $77,892 | $608,543 |
| CHIEF FINANCIAL OFFICER Officer, 38.00 hrs/week | $507,875 | $0 | $81,657 | $589,532 |
| SVP, GBL HEALTH & MANUFACTURING SVCS Key employee, 38.00 hrs/week | $527,212 | $0 | $52,400 | $579,612 |
| SVP REGIONS & PROGRAM OPS.(TO 6/25) Highest compensated employee, 38.00 hrs/week | $490,928 | $0 | $37,430 | $528,358 |
683 people received more than $100,000 in reportable compensation from United States Pharmacopeial Convention (Part VII, line 2). Compensation of current officers, directors and key employees totaled $6.9M (Part IX, line 5).
6 years of filings
Form 990, Parts I, VII, IX and X · each row is that year's own filing, linkedGovernance answers, as filed
FY2025 · the organization's own yes/no answers; explanations, if any, are in Schedule O of the filing · what each means- Voting board members, and how many are independent Part VI, lines 1a–1b13 · 13 independent
- Audited financial statements Part XII 2bYes
- Conflict-of-interest policy Part VI 12aYes
- Whistleblower policy Part VI 13Yes
- Document retention policy Part VI 14Yes
- Independent process for top executive pay Part VI 15aYes
- Board given the 990 before filing Part VI 11aYes
- Family or business ties among insiders Part VI 2No
- Aware of a significant diversion of assets Part VI 5No
- Excess benefit transaction with an insider Part IV 25aNo
- Loans to or from insiders outstanding Part IV 26No
- Lobbying, or a 501(h) election in effect Part IV 4Yes
- Over $15,000 of professional fundraising services Part IV 18No
- Over $10,000 of activity outside the U.S. Part IV 14bYes
- Employees Part I, line 5941
- Volunteers Part I, line 6657
Largest outside contractors
FY2025 · Form 990, Part VII, Section B · businesses only| RUDER FINN INC Consulting | $2,776,905 |
| VELOCITY GLOBAL LLC Consulting | $2,390,094 |
| ERNST & YOUNG LLP Consulting | $2,066,599 |
| ABM INDUSTRY GROUPS LLC Facilities services | $1,978,299 |
| BELL TECHLOGIX INC It services | $1,587,324 |
Individuals listed as contractors are left out. 60 contractors were paid more than $100,000 in all.
Correct a figure or respond
Every number above is copied from United States Pharmacopeial Convention's own Form 990. If one doesn't match the filing, that's our error and we'll fix it. If you work for United States Pharmacopeial Convention, you can publish a response that is linked from this page.
Share or embed this breakdown
Of every $100 United States Pharmacopeial Convention spent in FY2025, $71.22 went to programs. The full breakdown, from its IRS Form 990:
Embed on your site
Similar-sized charities in this cause
- Ascension ProvidenceSt Louis, MO · revenue $357M · programs 81.3% · FY2025
- Doctors HospitalCoral Gables, FL · revenue $358M · programs 90.2% · FY2025
- Galion Community HospitalGalion, OH · revenue $357M · programs 98.9% · FY2025
- Catholic Managed Long Term CARENew York, NY · revenue $358M · programs 89.1% · 2024
- Texas Health HuguleyBurleson, TX · revenue $357M · programs 91.7% · 2024
Questions people ask
How much of United States Pharmacopeial Convention's spending goes to programs?
In the fiscal year ending June 30, 2025, United States Pharmacopeial Convention reported that 71.2% of its $333.6 million in expenses went to program services, 28.5% to management and general and 0.3% to fundraising (Form 990, Part IX).
How much does United States Pharmacopeial Convention pay its top executive?
The largest total compensation United States Pharmacopeial Convention reported for one person in the fiscal year ending June 30, 2025 was $1,104,534, for the role of CHIEF EXECUTIVE OFFICER & EX-OFFICIO (Form 990, Part VII, including compensation from related organizations and other compensation).
Where does United States Pharmacopeial Convention get its money?
Of $357.7 million in revenue in the fiscal year ending June 30, 2025, 6.6% came from contributions and grants (including 6.1% from government grants) and 87.2% from program service revenue (Form 990, Part VIII).
Is United States Pharmacopeial Convention a registered charity?
The IRS lists EIN 13-1656692 as a 501(c)(3) organization (publicly supported organization (509(a)(2))), and its records show contributions as tax-deductible. Form 990 filings on record here cover tax years 2019, 2020, 2021, 2022, 2023, 2024. A filing shows what the organization reported; it doesn't by itself show whether a program works.
Sources
- FY2025: Form 990 for the fiscal year ending June 30, 2025, object 202513179349305956 · read the filing · XML
- FY2024: Form 990 for the fiscal year ending June 30, 2024, object 202403199349304765 · read the filing
- FY2023: Form 990 for the fiscal year ending June 30, 2023, object 202313179349303281 · read the filing
- FY2022: Form 990 for the fiscal year ending June 30, 2022, object 202203199349308200 · read the filing
- FY2021: Form 990 for the fiscal year ending June 30, 2021, object 202113199349304851 · read the filing
- FY2020: Form 990 for the fiscal year ending June 30, 2020, object 202043219349311329 · read the filing
All filings for EIN 13-1656692: ProPublica Nonprofit Explorer · IRS Tax Exempt Organization Search. Figures are as the organization reported them; we have not audited them.